Remove 2019 Remove Kidney Disease Remove Strokes
article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Data on major cardiovascular events (MACE; mortality, myocardial infarction, stroke, heart failure) through December 2021 were obtained from national registries. vs. 10.5%) and chronic kidney disease (3.7% vs. 6.8%), myocardial infarction (7.7% 1.00, p = 0.045), while 1-year mortality was unchanged.

article thumbnail

National A-Fib Numbers Higher Than Previously Thought

DAIC

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 percent of the patients treated between 2005 and 2009 to 6.82% of the patients treated between 2015 and 2019. million U.S.

article thumbnail

Abstract WP319: Reliability and validity of self-reported risk factors for stroke and dementia

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP319-AWP319, February 1, 2025. Reliability of self-reported risk factors was high in overweight (F1 0.81) and diabetes (F1 0.71), moderate in hearing impairment (F1 0.59) and hypertension (F1 0.56) and low in hypercholesterolemia (F1 0.49) and kidney disease (F1 0.25).

article thumbnail

America’s Growing CVD Problem

CardiacWire

Heart Disease in 2050 – The AHA warned of massive heart disease increases by 2050, spanning CVD (+60%), diabetes (+100%), obesity (+70%), hypertension (+44%), heart failure (+66%), and stroke (+100%). Add all that up and the cost of treating adult CVD and stroke patients will increase by 195% to $1.85

AFIB 59
article thumbnail

Abstract WP278: Trends in GLP1RA and SGLT2i Use in Ischemic Stroke Patients With Diabetes

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page AWP278-AWP278, February 1, 2024. Background:The current AHA stroke prevention guidelines give Class 1 recommendations that patients with AIS and diabetes should receive glucose-lowering agents with cardiovascular benefit to reduce risk of MACE.

article thumbnail

Abstract 52: Predictors of Mortality in Patients With Various Rheumatological Conditions Admitted for Stroke: Findings From National Inpatient Sample 2020

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page A52-A52, February 1, 2024. Background/Purpose:Stroke imposes a substantial healthcare burden, with ischemic stroke (IS) mortality rising from 2.04 million (2019) and projected to reach 4.90 million by 2030 according to the Global Burden of Disease Study. million (1990) to 3.29

article thumbnail

National A-Fib Numbers Higher Than Previously Tought

DAIC

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 percent of the patients treated between 2005 and 2009 to 6.82% of the patients treated between 2015 and 2019. million U.S.